Assessment of the CHA2DS2-VASc Score in Predicting Mortality and Adverse Cardiovascular Outcomes of Patients on Hemodialysis.
CONCLUSIONS: Patients with ESRD are at an extremely high mortality and cardiovascular risk within the first year of hemodialysis. The CHA2DS2-VASc score was strongly associated with adverse outcomes and may be used for risk stratification of these patients.
PMID: 32702703 [PubMed - as supplied by publisher]
Source: American Journal of Nephrology - Category: Urology & Nephrology Authors: Schamroth Pravda M, Cohen Hagai K, Topaz G, Schamroth Pravda N, Makhoul N, Shuvy M, Benchetrit S, Assali A, Pereg D Tags: Am J Nephrol Source Type: research
More News: Cardiology | Cardiovascular | Dialysis | Heart | Heart Attack | Hemodialysis | Stroke | Study | Switzerland Health | Urology & Nephrology